Patients LSX2026: On promise and patience, with Hans Schambye At LSX World Congress 2026 in Lisbon, Portugal, web editor Nicole Raleigh spoke with Hans Schambye, CEO of BOOST Pharma.
News FDA greenlights Roche’s biomarker blood test for Alzheimer's Roche has won US FDA clearance for a blood test that could move Alzheimer’s biomarker testing further into primary care.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
